Nasogastric Tube in Premature Babies - Pain and Treatment - Full Text View

Nasogastric Tube in Premature Babies - Pain and Treatment

This study has been completed.

Sponsors and Collaborators:	Norwegian University of Science and Technology St. Olavs Hospital
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00218946

Purpose

Does sucrose or pacifier influence pain in premature babies when a nasogastric tube is inserted?

Condition	Intervention	Phase
Infant, Premature	Drug: Sucrose Device: Pacifier	Phase II

MedlinePlus related topics:

Premature Babies

ChemIDplus related topics:

Sucrose

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Other, Randomized, Single Blind (Caregiver), Placebo Control, Factorial Assignment, Efficacy Study

Official Title:	Nasogastric Tube in Premature Babies - Pain and Treatment. A Randomised, Partly Blinded, Placebo-Controlled Factorial Clinical Trial of Sucrose and Pacifier

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:

Pain measured on PIPP (Premature Infant Pain Profile) scale [ Time Frame: 4 week to complete ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Enrollment:	24
Study Start Date:	January 2005
Study Completion Date:	August 2007
Estimated Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

Detailed Description:

A total of 24 premature babies are randomised to receive either placebo (sterile water), 30 % sucrose, or pacifier in a complete factorial, cross-over design. Pain is rated on the PIPP scale by observers blinded to the procedure other than use of pacifier.

Eligibility

Ages Eligible for Study:	up to 8 Weeks
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

28 - 32 weeks gestational weeks
not on mechanical ventilation

Exclusion Criteria:

high risk group regarding cerebral prognosis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218946

Locations


Norway
	St. Olavs University Hospital
	Trondheim, Norway, N-7006

Sponsors and Collaborators

Norwegian University of Science and Technology

St. Olavs Hospital

Investigators


Study Director:	Eirik Skogvoll, MD, PhD	Norwegian University of Science and Technology

More Information

Publications:

Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996 Mar;12(1):13-22.

Responsible Party:	Norwegian University of Science and Technology ( Eirik Skogvoll, MD PhD )
Study ID Numbers:	NISE-2005-1
First Received:	September 20, 2005
Last Updated:	January 31, 2008
ClinicalTrials.gov Identifier:	NCT00218946
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:

pain,premature,nasogastric tube,PIPP

Study placed in the following topic categories:

Pain

ClinicalTrials.gov processed this record on August 28, 2008